تيسينترك 840 مجم فيال

tecentriqï- is a monoclonal antibody designed to bind with a protein called pd-l1 expressed on tumour cells and tumour-infiltrating immune cells blocking its interactions with both pd-1 and b7.1 receptors. by inhibiting pd-l1 tecentriq may enable the acti